Verona Pharma Plc

... ...
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 0.00%78.725.6%$203.03m
VRXValeant Pharmaceuticals International, Inc. 0.02%26.3814.1%$155.22m
CTLTCatalent, Inc. 0.00%115.502.1%$113.12m
BHCBausch Health Cos., Inc. 0.02%26.380.0%$93.53m
JAZZJazz Pharmaceuticals Plc 0.00%167.712.4%$90.50m
UTHRUnited Therapeutics Corp. 0.00%172.8214.1%$69.47m
SAGESAGE Therapeutics, Inc. 0.00%91.387.6%$54.80m
ACSTAcasti Pharma, Inc. 0.00%0.600.2%$50.70m
PRGOPerrigo Co. Plc -0.05%43.696.8%$50.20m
GWPHGW Pharmaceuticals Plc 0.00%135.736.1%$47.13m
AMRNAmarin Corp. Plc 0.00%6.071.5%$46.60m
ISRIsoRay, Inc. -1.52%1.952.5%$45.38m
ICLRICON plc 0.00%210.354.2%$41.84m
ICPTIntercept Pharmaceuticals, Inc. 0.00%27.4516.8%$38.13m
PCRXPacira Biosciences, Inc. 0.00%73.6810.0%$37.63m

Company Profile

Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.